Siegel B, Gurevich D, Oxenkrug G F
Department of Geriatric Psychiatry, Lafayette Clinic, Detroit, MI 48207.
Biol Psychiatry. 1989 Jan 15;25(2):229-34. doi: 10.1016/0006-3223(89)90168-6.
The present study evaluates the relationship between cognitive impairment and the Dexamethasone Suppression Test (DST) in elderly persons suffering from depression. Twenty-nine subjects meeting DSM-III criteria for major depressive disorder (MDD) were assessed using the Global Deterioration Scale (GDS) and the DST. Plasma cortisol levels before and after receiving 0.5 mg dexamethasone were compared, and correlations were determined between GDS and postdexamethasone plasma cortisol levels. The results show that there is a positive correlation between the GDS scores and post-DEX cortisol levels (r = 0.57, p less than 0.005). It is suggested that increased activity of the HPA axis, seen in depression, could contribute to the cognitive impairments observed in this disorder.
本研究评估了老年抑郁症患者认知障碍与地塞米松抑制试验(DST)之间的关系。使用总体衰退量表(GDS)和DST对29名符合《精神疾病诊断与统计手册第三版》(DSM-III)中重度抑郁症(MDD)标准的受试者进行了评估。比较了接受0.5毫克地塞米松前后的血浆皮质醇水平,并确定了GDS与地塞米松给药后血浆皮质醇水平之间的相关性。结果表明,GDS评分与地塞米松给药后皮质醇水平之间存在正相关(r = 0.57,p < 0.005)。研究表明,抑郁症中观察到的下丘脑-垂体-肾上腺(HPA)轴活性增加可能导致该疾病中出现的认知障碍。